Mechanism of ERK/CREB pathway in pain and analgesia

Weizhe Zhen1,2, Hongjun Zhen3, Yuye Wang2,4

  • 1Graduate School, Beijing University of Chinese Medicine, Beijing, China.

Insights

The ERK/CREB pathway is crucial in pain and pain relief. This review details its role in pain, analgesia, and potential nervous system side effects from related drugs, offering solutions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Pain pathophysiology research often focuses on Transient Receiver Potential (TRP) channels.
  • The Extracellular Signal-Regulated Kinase/CAMP Response Element Binding Protein (ERK/CREB) pathway's role in pain and analgesia is under-researched.
  • Analgesics targeting the ERK/CREB pathway may present adverse effects requiring medical attention.

Purpose of the Study:

  • To systematically review the ERK/CREB pathway's mechanism in pain and analgesia.
  • To analyze potential adverse neurological effects of ERK/CREB pathway inhibition by analgesics.
  • To propose solutions for managing these adverse effects.

Main Methods:

  • Systematic literature review and synthesis.
  • Analysis of molecular mechanisms.
  • Review of clinical data on analgesic side effects.

Main Results:

  • The ERK/CREB pathway significantly influences pain signaling and resolution.
  • Inhibition of this pathway can lead to various central and peripheral nervous system adverse effects.
  • Specific analgesic mechanisms and their associated neurological risks were identified.

Conclusions:

  • Understanding the ERK/CREB pathway is vital for developing effective and safe analgesics.
  • Targeted therapeutic strategies are needed to mitigate adverse effects.
  • Further research should focus on pathway-specific interventions and neuroprotection.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
694
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain.
28.2K
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
532
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.7K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.2K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
7.6K